Safety and immunogenicity of the Merck adenovirus serotype 5 (MRKAd5) and MRKAd6 human immunodeficiency virus type 1 trigene vaccines alone and in combination in healthy adults (Clinical and Vaccine Immunology (2009) 16, 9 (1285-1292))

Clayton Harro; Xiao Sun; Jon E. Stek; Randi Y. Leavitt; Devan V. Mehrotra; Fubao Wang; Andrew J. Bett; Danilo R. Casimiro; John W. Shiver; Mark J. Dinubile; Erin Quirk

doi:10.1128/CVI.00473-09

Safety and immunogenicity of the Merck adenovirus serotype 5 (MRKAd5) and MRKAd6 human immunodeficiency virus type 1 trigene vaccines alone and in combination in healthy adults (Clinical and Vaccine Immunology (2009) 16, 9 (1285-1292))

Clayton Harro, Xiao Sun, Jon E. Stek, Randi Y. Leavitt, Devan V. Mehrotra, Fubao Wang, Andrew J. Bett, Danilo R. Casimiro, John W. Shiver, Mark J. Dinubile, Erin Quirk

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	204
Number of pages	1
Journal	Clinical and Vaccine Immunology
Volume	17
Issue number	1
DOIs	https://doi.org/10.1128/CVI.00473-09
State	Published - Jan 2010
Externally published	Yes

ASJC Scopus subject areas

Immunology and Allergy
Immunology
Clinical Biochemistry
Microbiology (medical)

Access to Document

10.1128/CVI.00473-09

Cite this

Harro, C., Sun, X., Stek, J. E., Leavitt, R. Y., Mehrotra, D. V., Wang, F., Bett, A. J., Casimiro, D. R., Shiver, J. W., Dinubile, M. J., & Quirk, E. (2010). Safety and immunogenicity of the Merck adenovirus serotype 5 (MRKAd5) and MRKAd6 human immunodeficiency virus type 1 trigene vaccines alone and in combination in healthy adults (Clinical and Vaccine Immunology (2009) 16, 9 (1285-1292)). Clinical and Vaccine Immunology, 17(1), 204. https://doi.org/10.1128/CVI.00473-09

Safety and immunogenicity of the Merck adenovirus serotype 5 (MRKAd5) and MRKAd6 human immunodeficiency virus type 1 trigene vaccines alone and in combination in healthy adults (Clinical and Vaccine Immunology (2009) 16, 9 (1285-1292)). / Harro, Clayton; Sun, Xiao; Stek, Jon E. et al.
In: Clinical and Vaccine Immunology, Vol. 17, No. 1, 01.2010, p. 204.

Research output: Contribution to journal › Comment/debate › peer-review

Harro, C, Sun, X, Stek, JE, Leavitt, RY, Mehrotra, DV, Wang, F, Bett, AJ, Casimiro, DR, Shiver, JW, Dinubile, MJ & Quirk, E 2010, 'Safety and immunogenicity of the Merck adenovirus serotype 5 (MRKAd5) and MRKAd6 human immunodeficiency virus type 1 trigene vaccines alone and in combination in healthy adults (Clinical and Vaccine Immunology (2009) 16, 9 (1285-1292))', Clinical and Vaccine Immunology, vol. 17, no. 1, pp. 204. https://doi.org/10.1128/CVI.00473-09

Harro C, Sun X, Stek JE, Leavitt RY, Mehrotra DV, Wang F et al. Safety and immunogenicity of the Merck adenovirus serotype 5 (MRKAd5) and MRKAd6 human immunodeficiency virus type 1 trigene vaccines alone and in combination in healthy adults (Clinical and Vaccine Immunology (2009) 16, 9 (1285-1292)). Clinical and Vaccine Immunology. 2010 Jan;17(1):204. doi: 10.1128/CVI.00473-09

@article{0cddeb5744f346a0ad5abc6fcc46c961,

title = "Safety and immunogenicity of the Merck adenovirus serotype 5 (MRKAd5) and MRKAd6 human immunodeficiency virus type 1 trigene vaccines alone and in combination in healthy adults (Clinical and Vaccine Immunology (2009) 16, 9 (1285-1292))",

author = "Clayton Harro and Xiao Sun and Stek, {Jon E.} and Leavitt, {Randi Y.} and Mehrotra, {Devan V.} and Fubao Wang and Bett, {Andrew J.} and Casimiro, {Danilo R.} and Shiver, {John W.} and Dinubile, {Mark J.} and Erin Quirk",

year = "2010",

month = jan,

doi = "10.1128/CVI.00473-09",

language = "English (US)",

volume = "17",

pages = "204",

journal = "Clinical and Vaccine Immunology",

issn = "1556-6811",

publisher = "American Society for Microbiology",

number = "1",

}

TY - JOUR

T1 - Safety and immunogenicity of the Merck adenovirus serotype 5 (MRKAd5) and MRKAd6 human immunodeficiency virus type 1 trigene vaccines alone and in combination in healthy adults (Clinical and Vaccine Immunology (2009) 16, 9 (1285-1292))

AU - Harro, Clayton

AU - Sun, Xiao

AU - Stek, Jon E.

AU - Leavitt, Randi Y.

AU - Mehrotra, Devan V.

AU - Wang, Fubao

AU - Bett, Andrew J.

AU - Casimiro, Danilo R.

AU - Shiver, John W.

AU - Dinubile, Mark J.

AU - Quirk, Erin

PY - 2010/1

Y1 - 2010/1

UR - http://www.scopus.com/inward/record.url?scp=74549173677&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=74549173677&partnerID=8YFLogxK

U2 - 10.1128/CVI.00473-09

DO - 10.1128/CVI.00473-09

M3 - Comment/debate

AN - SCOPUS:74549173677

SN - 1556-6811

VL - 17

SP - 204

JO - Clinical and Vaccine Immunology

JF - Clinical and Vaccine Immunology

IS - 1

ER -

Safety and immunogenicity of the Merck adenovirus serotype 5 (MRKAd5) and MRKAd6 human immunodeficiency virus type 1 trigene vaccines alone and in combination in healthy adults (Clinical and Vaccine Immunology (2009) 16, 9 (1285-1292))

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this